In addition, although the 11q13 amplification contributes to Ano1 overexpression in human breast cancer [15], it is unlikely the major contributor to Ano1 overexpression in PR-positive tumors, because the 11q13 amplification only occurs in approximately 15% of human breast cancer [34]. Here, ANO1 is linked to breast carcinoma.